| Website | evolva.com |
| Category | BioTech |
| Phone | 41-61-485-2000 |
| info@evolva.com | |
| Employees | |
| Founded | 2004 |
| TOTAL | $43.5M |
| FUNDING TOTAL | $43.5M |
| Series B, 12/09 Aravis Ventures Auriga Partners VINCI CAPITAL Wellington Partners | $27.5M |
| Series B, 12/09 Novartis Venture Funds Dansk Innovation Auriga Partners Wellington Partners BioMedinvest VINCI CAPITAL Entrepreneurs Fund | $16M |
Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small molecule drugs and other compounds. In particular their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.
